Literature DB >> 28767536

Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.

Kristina T Phillips1, Bradley J Anderson, Debra S Herman, Jane M Liebschutz, Michael D Stein.   

Abstract

OBJECTIVES: Skin and soft tissue infections (SSTIs) are common among people who inject drugs (PWID), and can lead to serious morbidity and costly emergency room and hospital utilization. A range of high-risk injection practices may contribute to these infections. The goal of the current study was to examine risk practices that were associated with SSTIs in a sample of hospitalized PWID.
METHODS: PWID (N = 143; 40.6% female) were recruited from inpatient medical units at a large urban hospital and completed a baseline interview that focused on infection risk. Measures included demographics, substances used/injected, and self-report of SSTIs (ie, abscesses, ulcers, or cellulitis) within the past year. The Bacterial Infections Risk Scale for Injectors-a 7-item index-assessed specific behaviors expected to increase the risk of acquiring SSTIs (eg, injection without skin cleaning, intramuscular injection).
RESULTS: The sample was 58% Caucasian and averaged 38.7 (SD = 10.7) years of age. Ninety-three participants (65%) reported at least 1 SSTI within the past year. Using a logistic regression model, the Bacterial Infections Risk Scale for Injectors (odds ratio 1.87, P = 0.004) and total number of injections over the past 3 months (odds ratio 2.21, P = 0.002) were associated with past year SSTIs.
CONCLUSIONS: In conclusion, rates of past-year SSTIs were high in this sample of hospitalized PWID. Results suggest that interventions should target specific injection practices to reduce infection risk.

Entities:  

Mesh:

Year:  2017        PMID: 28767536      PMCID: PMC5659886          DOI: 10.1097/ADM.0000000000000346

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  48 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Risk practices associated with bacterial infections among injection drug users in Denver, Colorado.

Authors:  Kristina T Phillips; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2010-03       Impact factor: 3.829

3.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

Review 4.  Bacterial infections in drug users.

Authors:  Rachel J Gordon; Franklin D Lowy
Journal:  N Engl J Med       Date:  2005-11-03       Impact factor: 91.245

5.  Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.

Authors:  Elisa Lloyd-Smith; Evan Wood; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2008-09-20       Impact factor: 4.492

6.  Wound botulism associated with black tar heroin among injecting drug users.

Authors:  D J Passaro; S B Werner; J McGee; W R Mac Kenzie; D J Vugia
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

7.  Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.

Authors:  E L Murphy; D DeVita; H Liu; E Vittinghoff; P Leung; D H Ciccarone; B R Edlin
Journal:  Clin Infect Dis       Date:  2001-06-05       Impact factor: 9.079

8.  Predictors of bacterial infections among HCV-negative injection drug users in Rhode Island.

Authors:  Kristina T Phillips; Bradley J Anderson; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

9.  Not in the vein: 'missed hits', subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom.

Authors:  V D Hope; J V Parry; F Ncube; M Hickman
Journal:  Int J Drug Policy       Date:  2015-11-17

10.  Women's injection drug practices in their own words: a qualitative study.

Authors:  Ellen Tuchman
Journal:  Harm Reduct J       Date:  2015-03-07
View more
  14 in total

1.  Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.

Authors:  Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2019-11-24

2.  A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.

Authors:  Jenny E Ozga; Jennifer L Syvertsen; John A Zweifler; Robin A Pollini
Journal:  Health Soc Care Community       Date:  2021-09-01

Review 3.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

4.  Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study.

Authors:  Joshua A Barocas; Golnaz Eftekhari Yazdi; Alexandra Savinkina; Shayla Nolen; Caroline Savitzky; Jeffrey H Samet; Honora Englander; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

5.  Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Authors:  Raagini Jawa; Michael D Stein; Bradley Anderson; Jane M Liebschutz; Catherine Stewart; Kristina T Phillips; Joshua A Barocas
Journal:  Int J Drug Policy       Date:  2021-03-18

6.  Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England.

Authors:  Dan Lewer; Vivian D Hope; Magdalena Harris; Michael Kelleher; Amelia Jewell; Megan Pritchard; John Strang; Katherine I Morley
Journal:  Drug Alcohol Depend       Date:  2020-05-06       Impact factor: 4.492

7.  Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users.

Authors:  Salequl Islam; Damani A Piggott; Alberto Moriggia; Jacquie Astemborski; Shruti H Mehta; David L Thomas; Gregory D Kirk
Journal:  Harm Reduct J       Date:  2019-06-17

8.  The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts.

Authors:  Gregg S Gonsalves; A David Paltiel; Thomas Thornhill; Suzan Iloglu; Alfred DeMaria; Kevin Cranston; R Monina Klevens; Rochelle P Walensky; Joshua L Warren
Journal:  Open Forum Infect Dis       Date:  2021-03-15       Impact factor: 4.423

9.  The impact of the COVID-19 pandemic on harm reduction services in Spain.

Authors:  Camila A Picchio; Jorge Valencia; Jason Doran; Tracy Swan; Marta Pastor; Elisa Martró; Joan Colom; Jeffrey V Lazarus
Journal:  Harm Reduct J       Date:  2020-11-04

10.  Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain.

Authors:  Jorge Valencia; Jesús Troya; Jeffrey V Lazarus; Guillermo Cuevas; Alejandro Alvaro-Meca; Juan Torres; Carlos Gardeta; David Lozano; Santiago Moreno; Pablo Ryan
Journal:  Open Forum Infect Dis       Date:  2021-05-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.